DESIPRAMINE AND IMIPRAMINE IN AN OUTPATIENT SETTING: A COMPARATIVE STUDY
Abstract
In a comparative study, 40 outpatients, each having a depressive syndrome as the principal clinical feature, were treated with either desipramine or imipramine. Fourteen patients on each drug completed the study. The efficacy of both drugs as antidepressants was found to be in the same range. Desipramine had a more rapid onset of action than imipramine and produced slightly fewer side effects. The difference between the number of days for onset of action and the number of side effects with both drugs is not statistically significant. The majority of patients on each drug responded well to treatment.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
